title: GABAergic modulation of developing pedunculopontine nucleus.
abstract: Rapid eye movement sleep decreases dramatically during development. We tested the hypothesis that some of this decrease may be due to GABAergic inhibition of reticular activating system neurons. Recordings of pedunculopontine neurons in vitro showed that the gamma-amino-butyric acid, receptor agonist muscimol depolarized noncholinergic cells early in the developmental decrease in rapid eye movement sleep, and hyperpolarized them later. Most cholinergic cells were hyperpolarized throughout the period tested. The gamma-amino-butyric acid b receptor agonist baclofen hyperpolarized both cholinergic and noncholinergic cells, although the degree of polarization decreased with age. Part of the gradual decrement in rapid eye movement sleep during development may be due in part to the increasing inhibition mediated by gamma-amino-butyric acid, a receptor on pedunculopontine neurons. This influence, however, appears to be mainly on noncholinergic cells.
authors.affiliation: Center for Translational Neuroscience, Department of Neurobiology & Developmental Sciences, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Bay
authors.forename: Paige
authors.initials: P
authors.lastname: Beck
authors.forename: Robert D
authors.initials: RD
authors.lastname: Skinner
authors.forename: Edgar
authors.initials: E
authors.lastname: Garcia-Rill
mesh_terms: D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000375:Aging / Q000502:physiology; D000818:Animals; D001418:Baclofen / Q000494:pharmacology; D018755:GABA Agonists / Q000494:pharmacology; D058788:GABA-B Receptor Antagonists; D009118:Muscimol / Q000494:pharmacology; D009433:Neural Inhibition / Q000502:physiology*; D009434:Neural Pathways / Q000254:growth & development / Q000378:metabolism; D045042:Pedunculopontine Tegmental Nucleus / Q000254:growth & development* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D018080:Receptors, GABA-B / Q000378:metabolism; D012154:Reticular Formation / Q000254:growth & development* / Q000378:metabolism; D012895:Sleep, REM / Q000187:drug effects / Q000502:physiology*; D026941:Sodium Channel Blockers / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism*
chemical_list: D018755:GABA Agonists; D058788:GABA-B Receptor Antagonists; D018080:Receptors, GABA-B; D026941:Sodium Channel Blockers; D009118:Muscimol; D005680:gamma-Aminobutyric Acid; D001418:Baclofen